Learn more
Advanced Search

The Big Problem in the Rubber Industry

By Tom Dyson, publisher, The Palm Beach Letter
Wednesday, August 20, 2008

In the 1840s, Charles Goodyear invented the process that turns the soft gum from the rubber tree into the hard rubber used in tires or mats or shoe soles.

The process is called vulcanization.

Vulcanization is a chemical reaction between the rubber, sulfur, and other chemicals. It makes rubber much stronger, more pliable, and durable.


The problem with vulcanization is, there's no way to reverse it. So once you've turned the rubber into a tire, there's no way of recycling it. As the situation stands today, we burn old tires in power plants and cement kilns. It's less polluting than coal, but it still releases thousands of toxins into the air.

Grinding old rubber into crumbs and mixing it with asphalt to make roads is another way we dispose of old tires. Or we mix the crumbs with glue to make running tracks and playground surfaces.

Last year, the world discarded 1.3 billion tires. Americans change 300 million tires every year. Here's what America does with its old tires:

45%

burned for fuel

19%

civil engineering

10%

size reduction

10%

unknown

9%

landfill

4%

other

3%

dumped in third-world countries

The person who finds a way to reverse the vulcanization process and turn car tires back into "virgin rubber" will make a fortune. And that's exactly what Vinod Sekhar says he's got... and he thinks it's going to make him a billionaire.

With a $350 million fortune, Vinod is the 16th richest person in Malaysia. He started his fortune selling T-shirts with college logos in the United States. Now he owns Petra Group, a company with interests in financial software, Internet provision, movies, publishing, and more.

I'm traveling around Asia looking for investment opportunities. I met Vinod last week in Kuala Lumpur. He calls his new technology "Green Rubber" and says it's going to revolutionize the rubber industry...

Vinod has a patent on a product called DeLink. When you mix this product with crumbed rubber, two parts DeLink to 100 parts rubber, you get a chemical reaction that turns vulcanized rubber into virgin rubber... or Green Rubber.

Vinod's Green Rubber is half the price of regular rubber. It helps the environment. And Vinod says it performs as well as regular rubber in the major applications.

Consumers will love Green Rubber. But just in case they don't, the U.S. House of Representatives just introduced the TIRE Act of 2008. The U.S. government wants to create a recycled rubber industry. This act provides a $3-per-tire tax incentive for purchasers of tires made from recycled rubber.

Vinod's big problem is the rubber industry. The rubber industry is one of the most conservative, traditional industries there is. Green Rubber is a disruptive technology. The old guard will resist this change with all its might...


In the meantime, I'm heading to Singapore to look for more investment ideas...Will Vinod's green rubber company revolutionize the rubber industry, as he says? It is an interesting story... and I'm definitely going to keep an eye on Vinod.

Good investing,

Tom

Editor's note: Tom Dyson is a regular contributor to DailyWealth, a free investment newsletter focused on the world's best contrarian opportunities. We write with a simple belief in mind: You don't have to take big risks to make big money with your investments. 







WHAT'S DRIVING THE BIOTECH BULL MARKET

A "big trend" our colleague Rob Fannon let us in on is kicking into high gear.

Rob is one of the top medical and drug stock analysts in the business. For the past several years, he's told Growth Stock Wire readers about the huge coming "buyout" spree led by big drug companies. This spree could easily send the prices of many biotech stocks to the moon.

Big drugmakers are a lot like big oil producers. They have to constantly replenish "reserves" as older drugs come off patent or get upstaged by new technologies. So pharmaceutical companies constantly scour the stock market in search of new drugs. If they find companies that fit into their businesses, they'll buy them whole. It's cleaner and easier than spending 10 years on new testing and research.

Right now, large drug companies are trying to buy two gigantic biotech firms, ImClone and Genentech. And the biotech sector as a whole is up 30% since March. Expect a ton of news about more buyouts in the future.

Learn about the top drug companies by sifting through the holdings of XBI, an exchange-traded fund, or ETHSX, a widely respected mutual fund. We say it doesn't really matter how you pick the drug stocks... just make sure you're in 'em on the long side!


recent articles
  • What's Next for Your Gold Investment?
    By Dr. Steve Sjuggerud Tuesday, August 19, 2008
    We have no guarantees that gold will resume its bull market now, or ever. But history shows gold has fallen as much as 50% before continuing a huge bull market. That helps put the recent 20% fall in perspective.


  • Where to Find the Money in Asia
    By Tom Dyson Monday, August 18, 2008
    The goal of my trip around Asia is to find "the money" and tell my subscribers how to get it. Vinod isn't a trader or an investor. He's an entrepreneur. So I asked him, if he were a 22-year-old with $100,000 in his back pocket, and he could go anywhere in the world, where would he go to make his millions all over again...


  • The Ultimate Inflation Hedge Is Revealed...
    By Alex Green Saturday, August 16, 2008
  • The No. 1 Secret to Wealthy Living
    By Dr. Steve Sjuggerud Friday, August 15, 2008
    I define living well as 1) having time with friends and family, 2) pursuing my passions, and 3) well, not worrying about money. The nice thing is, you don't need a fortune to live well by that definition.


  • How to Know What Stocks to Buy, at Any Moment
    By Dr. Steve Sjuggerud Wednesday, August 13, 2008
    OK, so we know what NOT to buy... We DON'T want to buy things that have performed well over the last few years, when investors are getting giddy over the prospects for the future. This almost always means the assets are selling for ridiculously high prices, like tech stocks in 1999 and real estate in 2005.